Developmental Biology Program

The Mary Baylies Lab


Mary Baylies, PhD
Mary Baylies, PhD

Developmental biologist Mary Baylies studies the mechanisms that form and maintain muscle both during normal development and in disease.


View Lab Overview

Research Projects

The Baylies Lab



Mary Baylies, PhD

Mary Baylies, PhD

  • The Baylies laboratory studies the mechanisms that form and maintain muscle both during normal development and in disease.
  • PhD, The Rockefeller University
[email protected]
Email Address
Office Phone
Download CV
PDF File


Mary Baylies, PhD
Mary Baylies


David Soffar
David Soffar

Research Technician

Bianca Borchin

Research Fellow

Patrick Busch, Graduate Student
Patrick Busch

Graduate Student

Briana Christophers

Graduate Student

Meg Distini

Administrative Assistant

Therandë Jashari

Graduate Student

Ruth Silimon

Graduate Student

Victoria von Saucken

Graduate Student

Stefanie Windner
Stefanie Windner

Research Fellow

Carol Zapater i Morales
Carol Zapater i Morales

Graduate Student

Lab Alumni
Lab Affiliations


  • Developed a Drosophila model for metastasis in alveolar rhabdomyosarcoma, a type of soft tissue cancer most often seen in children
  • Demonstrated that properly placed nuclei are critical for healthy muscle function
  • Described how nuclear polarization occurs during myonuclear movement in vivo
  • Completed the first spatial and temporal characterization of an F-actin structure that forms at the myoblast fusion site
  • Identified transcription factors and chromatin regulators that are critical for muscle identity
Read more
  • Identified 3-D arrangement of myoblasts that occur during muscle specification and morphogenesis
  • Discovered signal transduction pathways (Notch, Wnt, BMP, and RTK) and transcription factors that are critical for muscle identity
  • President of the Society for Muscle Development (2009-2013)
  • Frederick Adler Chair for Junior Faculty (1997-2003)

Get in Touch


Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Mary Baylies discloses the following relationships and financial interests:

  • Atropos Therapeutics, Inc.
    Provision of Services (uncompensated)
  • French National Research Agency
    Provision of Services (uncompensated)

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2020 through disclosure submission in spring 2021). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].

View all disclosures